Rural Health
News by Topic: Infectious diseases
Aug 5, 2025 - Request for comments from the Health Resources and Services Administration on an information collection titled "Ending the HIV Epidemic (EHE) Initiative Triannual Report OMB No. 0915-0051—Extension." HRSA proposes to revise a footnote to provide clarity on existing instruction. Comments are due October 6, 2025.
Source: Federal Register
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
Jul 29, 2025 - The Food and Drug Administration (FDA) has revoked Emergency Use Authorizations issued to Regeneron Pharmaceuticals, Inc., for REGEN-COV (casirivimab and imdevimab administered together); GlaxoSmithKline LLC for sotrovimab; Eli Lilly and Company for bebtelovimab; and AstraZeneca Pharmaceuticals LP for EVUSHELD (tixagevimab co-packaged with cilgavimab). These revocations are effective December 13, 2024.
Source: Federal Register
DOD: TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments
Federal Register
Jul 28, 2025 - Notice of final rule from the Department of Defense (DOD) Defense Health Agency (DHA) finalizing provisions published in two interim final rules (IFRs) that temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. Among other things, this rule discusses the DOD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. This rule is effective August 27, 2025.
Source: Federal Register
Jun 26, 2025 - Notice from the Health Resources and Services
Administration (HRSA) seeking comments on an information
collection regarding a form related to the COVID-19
Provider Relief Fund (PRF) and American Rescue Plan (ARP)
rural payment reporting activities. The information
collection is used to assess if statutory and programmatic
requirements are met; conduct audits; report on findings
with respect to the disbursements of PRF and ARP Rural
payments; and for the program evaluation. Comments are due
by August 25, 2025.
Source: Federal Register
Jun 16, 2025 - The Centers for Disease Control and Prevention (CDC) is seeking comments on a proposed information collection project titled "National Healthcare Safety Network (NHSN) Respiratory Data." This information collection is designed to standardize the data elements collected from across the country regarding the impact of respiratory viruses on healthcare facilities. Comments are due by August 15, 2025.
Source: Federal Register
CDC: Solicitation of Nominations for Appointment to the Advisory Committee to the Director
Federal Register
Jun 16, 2025 - The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the Advisory Committee to the Director (ACD). The ACD consists of up to 15 experts knowledgeable in areas pertinent to the CDC mission, including public health, infectious disease, data science and Artificial Intelligence (AI), global health, public health preparedness, and related fields. Nominations are due by July 16, 2025.
Source: Federal Register